Adam Steinlauf

I am a specialist in the Inflammatory Bowel Diseases (IBD), Ulcerative Coltitis and Crohn's Disease @ Mount Sinai

[Mount Sinai Department of Medicine @DOMSinaiNYC]

We’re proud to celebrate the recipients of the Cullman Family Award for Excellence in Provider Communication at Mount Sinai. Congratulations to all honorees for ranking in the top 5% nationwide for outstanding, compassionate communication! #MountSinaiProud

[Adam Steinlauf @Adams1002]

Had a great time practicing with Tom Ullman for our reunion performance at this years CCF Gala.

[Adam Steinlauf @Adams1002]

Our paper on the beneficial effects of upadacitinib on quality of life in patients with Crohn’s Disease.

[Adam Steinlauf @Adams1002]

#MGoGrad

[Adam Steinlauf @Adams1002]

#MGoGrad

[Adam Steinlauf @Adams1002]

Great evening with colleagues and fellows!!

[Mount Sinai Hospital GI Fellowship Program @MSH_GI_Fellows]

Springtime at @MountSinaiGI means another round of Faculty Dining Series! (No bowel prep required.)

@Danny_WongMD @Typical_Brian @RababOun @HyderSaidMD @Adams1002 @ManasiAgrawalMD @brownbrij76 @jdclaytor @SalamBeahMD @JellyanaPeraza

[Adam Steinlauf @Adams1002]

https://t.co/0o3PZhKoen

[Adam Steinlauf @Adams1002]

@sydneyphlegar @TessaWestNYU Congratulations!!

[Adam Steinlauf @Adams1002]

Proud to be promoted to Professor of Medicine at Icahn School of Medicine, Mount Sinai Health System.

[Adam Steinlauf @Adams1002]

Our article on biosimilars for the ACG FDA-Related Matters Committee.

[AJG - The American Journal of Gastroenterology @AmJGastro]

In the 📕#RedJournal:

Overview of Biosimilars in Inflammatory Bowel Diseases
Feagins, et al.

👉 https://t.co/8ul0Td5QHN
@GimdGold @Adams1002

[AJG - The American Journal of Gastroenterology @AmJGastro]

In the 📕#RedJournal:

Overview of Biosimilars in Inflammatory Bowel Diseases
Feagins, et al.

👉 https://t.co/8ul0Td5QHN
@GimdGold @Adams1002

[Mount Sinai IBD Center @MSHS_IBDCenter]

If you suffer from IBD and your disease is difficult to control, or if you simply want to be involved in research that will change how we manage IBD, please feel free to fill out the following questionnaire to see if you qualify for a Mount Sinai trial:
https://t.co/KQcK9MLhuj

[Mount Sinai IBD Center @MSHS_IBDCenter]

Are you interested in participating in a clinical trial for Inflammatory Bowel Disease? If so, please fill out the following survey.

https://t.co/KQcK9MLhuj

[Adam Steinlauf @Adams1002]

So great to see everyone at the CCF Gala.

[Icahn School of Medicine at Mount Sinai @IcahnMountSinai]

Dr. Marla Dubinsky discusses a study that showed the efficacy of Mirikizumab in patients with ulcerative colitis, highlighting its durability via @medresearchnews, which led to the approval of Mirikizumab by the FDA: https://t.co/7K8PCTIzpN

@MSHS_IBDCenter @DOMSinaiNYC

[Mount Sinai Department of Medicine @DOMSinaiNYC]

Congratulations to Adam Steinlauf, MD, for receiving the prestigious 2023 Rosenthal Humanitarian of the Year Award from the Crohn's & Colitis Foundation. Thank you for your incredible contributions to the #IBD community, Dr. Steinlauf. @CrohnsColitisFn @MountSinaiGI #IBDAdvocacy

[Adam Steinlauf @Adams1002]

I’m excited to be this years Crohn’s & Colitis Foundation Rosenthal Humanitarian Award recipient. Please join me in supporting this important organization!!
https://t.co/9jn67zi3rJ

[Adam Steinlauf @Adams1002]

Our review article for the @AmCollegeGastro FDA-related Matters Committee.
Overview of biosimilars in inflammatory bowel diseases : Official journal of the American College of Gastroenterology | ACG https://t.co/ew5Bodz7pK

[Adam Steinlauf @Adams1002]

The CCF is committed to supporting patients and families who suffer from IBD and finding a cure for these diseases. Please join me as this years Humanitarian Award recipient in supporting this great organization. https://t.co/bnGvoUH5A4

[Adam Steinlauf @Adams1002]

@MSH_GI_Fellows @Danny_WongMD @JellyanaPeraza @jdclaytor @Typical_Brian Congrats everyone!!